Your browser doesn't support javascript.
loading
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Zhao, Wei; Hill, Helen; Le Guellec, Chantal; Neal, Tim; Mahoney, Sarah; Paulus, Stephane; Castellan, Charlotte; Kassai, Behrouz; van den Anker, Johannes N; Kearns, Gregory L; Turner, Mark A; Jacqz-Aigrain, Evelyne.
  • Zhao W; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, APHP, Paris, France Clinical Investigation Center CIC1426, INSERM, Paris, France EA7323, Université Paris Diderot-Un
  • Hill H; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom Neonatal Unit, Liverpool Women's Hospital, Liverpool, United Kingdom.
  • Le Guellec C; EA4245, Faculté de Médecine, Université François Rabelais, Tours, France.
  • Neal T; Department of Medical Microbiology, Royal Liverpool University Hospital, Liverpool, United Kingdom.
  • Mahoney S; Paediatric Intensive Care, Alder Hey Children's Hospital, Liverpool, United Kingdom.
  • Paulus S; Paediatric Intensive Care, Alder Hey Children's Hospital, Liverpool, United Kingdom.
  • Castellan C; CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Université de Lyon, EPICIME-CIC 1407-INSERM-Hospices Civils de Lyon, Lyon, France.
  • Kassai B; CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Université de Lyon, EPICIME-CIC 1407-INSERM-Hospices Civils de Lyon, Lyon, France.
  • van den Anker JN; Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands Division of Pediatric Clinical Pharmacology, Children's National Medical Center, Washington, DC, USA Departments of Pediatrics, Pharmacology, and Physiology, George Washington University, School of Medicine and Health
  • Kearns GL; Division of Clinical Pharmacology and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, Missouri, USA Department of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri, USA.
  • Turner MA; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom Neonatal Unit, Liverpool Women's Hospital, Liverpool, United Kingdom.
  • Jacqz-Aigrain E; Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, APHP, Paris, France Clinical Investigation Center CIC1426, INSERM, Paris, France EA7323, Université Paris Diderot-Université Paris Descartes, Paris, France evelyne.jacqz-aigrain@rdb.aphp.fr.
Antimicrob Agents Chemother ; 58(11): 6572-80, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25155587
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ciprofloxacina / Infecciones por Bacterias Gramnegativas / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ciprofloxacina / Infecciones por Bacterias Gramnegativas / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn Idioma: En Año: 2014 Tipo del documento: Article